|
|
Article: Cantel Medical's Crosstex Subsidiary Launches New Specially Treated Face Mask Effective Against H1N1 Influenza.
- Article from:
- PR Newswire
- Article date:
- October 13, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LITTLE FALLS, N.J., Oct. 13 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. , through its Crosstex International subsidiary, has launched a unique face mask treated with BIOSAFEA' antimicrobial in markets outside the United States. Crosstex' new BIOSAFE-treated Ultra Sensitive face masks begin to reduce microorganisms, such as MRSA, VRE and Staph, immediately upon contact. These treated face masks have proven to be effective against Influenza A strains, such as seasonal flu and the novel H1N1 virus.
Gary Steinberg, CEO of Crosstex, stated, "Face masks serve as the first line of defense against airborne particles by trapping them in the filter media. However, ...